Kevin Outterson
Company: CARB-X & Boston University
Job title: Executive Director & Professor of Law
Seminars:
Q&A/Discussion 10:15 am
day: Day One
Surviving FDA Approval of your Antibiotic 9:25 am
What can we learn from the past decade of FDA antibiotic approvals? Niche markets where your drug can differentiate from generics Non-dilutive funding: CARB-X, BARDA, HERA Exit: AMR Action Fund, PASTEURRead more
day: Day One